相似文献
1
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
Breast Cancer Res. 2005;7(6):R890-6. doi: 10.1186/bcr1319. Epub 2005 Sep 14.
2
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Breast Cancer Res. 2005;7(4):R513-21. doi: 10.1186/bcr1040. Epub 2005 May 12.
3
Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Exp Mol Med. 2005 Feb 28;37(1):11-7. doi: 10.1038/emm.2005.2.
4
CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Breast Cancer Res. 2005;7(4):R455-64. doi: 10.1186/bcr1027. Epub 2005 Apr 12.
5
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Cancer Res. 1999 Mar 1;59(5):1015-20.
6
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8.
7
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Cancer Res. 1997 Mar 15;57(6):1063-5.
8
The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Mutagenesis. 2002 Mar;17(2):119-26. doi: 10.1093/mutage/17.2.119.
9
No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.
Breast Cancer Res Treat. 2010 Jul;122(1):221-7. doi: 10.1007/s10549-009-0679-4. Epub 2009 Dec 15.
引用本文的文献
1
Association between CYP17 T-34C rs743572 and breast cancer risk.
Oncotarget. 2017 Dec 26;9(3):4200-4213. doi: 10.18632/oncotarget.23688. eCollection 2018 Jan 9.
2
Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?
Genet Epidemiol. 2016 Jul;40(5):356-65. doi: 10.1002/gepi.21967. Epub 2016 Apr 7.
3
CYP17 and breast cancer: no overall effect, but what about interactions?
Breast Cancer Res. 2005;7(6):238-42. doi: 10.1186/bcr1320. Epub 2005 Sep 20.
本文引用的文献
1
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Breast Cancer Res. 2005;7(4):R513-21. doi: 10.1186/bcr1040. Epub 2005 May 12.
2
CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Breast Cancer Res. 2005;7(4):R455-64. doi: 10.1186/bcr1027. Epub 2005 Apr 12.
3
Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
Breast Cancer Res. 2005;7(1):R71-81. doi: 10.1186/bcr951. Epub 2004 Nov 11.
4
Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer.
Breast Cancer Res Treat. 2004 Dec;88(3):217-30. doi: 10.1007/s10549-004-0780-7.
5
CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.
Breast Cancer. 2004;11(4):380-8. doi: 10.1007/BF02968046.
6
CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review.
Am J Epidemiol. 2004 Oct 15;160(8):729-40. doi: 10.1093/aje/kwh287.
7
Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Cancer. 2004 Jul 15;101(2):264-9. doi: 10.1002/cncr.20361.
8
Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
Breast Cancer Res. 2004;6(4):R437-49. doi: 10.1186/bcr811. Epub 2004 Jun 4.
9
Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
J Natl Cancer Inst. 2004 Jun 16;96(12):936-45. doi: 10.1093/jnci/djh167.
10
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):94-101. doi: 10.1158/1055-9965.epi-03-0026.
Zotero 插件